Skip to content

MEDI-CL

Active Private limited companyfounded 2021active for 5 yearsRue de Sierpont 29, 5340 GesvesKBO/BCE: BE 0764.406.322

Lifetime

5 annual accounts with figures on one time axis
peak €80,836 (2022)
€53,591▲ 103%
peak €57,332 (2022)
€34,564▲ 145%
peak €79,618 (2023)
€28,214unchanged
€104,929▲ 41.5%
Board1 name since 2021
1 director
Documentsfilings and deeds
20-04-2026102 days before the deadline
2025micro format
Gross margin from €26,421 to €53,591Result from €14,102 to €34,564Dividend €34,564Debts from €74,147 to €104,929Investments €39,231Cash from €76,565 to €47,205

Key points

from the 2025 annual accounts

Equity

€28,214 from €79,618 in 2023

Equity fell by 65% in 2 years.

Turnover

≈ €120,000 estimated

The micro format states no turnover.

Debts

€104,929 79% of the balance sheet
Financial debts 33%Taxes and wages 10%Other 57%

Of this, €70,127 falls due within a year.

Investments

€39,231 5.2 × depreciation
20212025

Green is investment, beige is depreciation.

Filings

5 annual accounts since 2021
AprilJune31 JulyOctober20222024

The last five annual accounts were filed 31 to 102 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as MEDI-CL has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for MEDI-CL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 02-03-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0764406322
Registered office moved from Ciergnon to Gesves New registered office: Rue de ISerpont 29 5340 Gesves · Previous registered office: Rue du Bonnier 1 5560 Ciergnon · Board meeting of 15-09-2023 · Gazette deed
Incorporation Founding capital of €100, 100 shares · Founder: (comparante) · Appointment: (director) · published on 02-03-2021 · Gazette deed
First establishment Rue de Sierpont 29, Gesves
All 12 events

Comparable companies

same main activity, similar in size and age
Company
MEDI-CL Gesves €133,143 €53,591 21.2% -
DR. A. STURTEWAGEN, URGENTIEGENEESKUNDE-ANESTHESIE Deinze €138,143 €52,371 1.5% -
Dr. André Marie-Sophie Beersel €138,969 €58,371 22.5% -
DR C. MALENGREAUX Waterloo €118,412 €56,476 6.8% -
Centre de Médecine Intégrative Assesse €162,927 €58,569 4.4% -
VD SKIN Eghezée €149,975 €66,961 0.7% -
Dr. Liesbet Vanderwegen Haacht €128,495 €54,474 34.0% -

These companies have the same main activity as MEDI-CL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €118,000 and €163,000, founded between 2019 and 2021.

Official details

Source: KBO
Status
Active since 26-02-2021Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.314.879.2645340 Gesves, since 26-02-2021
Financial year end
31 December
Peppol
Reachable since 30-12-2025
Company details

Annual accounts 2025

€133,143▲ 30.1%
Filing
Filed on 20-04-2026, 102 days before the end of the filing period
Financials

Insights on MEDI-CL

MEDI-CL files the micro format. That format states no turnover. The gross margin rose from €45,032 in 2021 to €53,591 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDI-CL

What is the company number of MEDI-CL?
The company number of MEDI-CL is 0764.406.322. The VAT number is the same number with BE in front: BE 0764.406.322.
Where is MEDI-CL based?
The registered office is at Rue de Sierpont 29, 5340 Gesves.Company details
What does MEDI-CL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDI-CL?
MEDI-CL is a private limited company (BV).
When was MEDI-CL founded?
MEDI-CL was founded on 26-02-2021.
Is MEDI-CL still active?
Yes, MEDI-CL is an active enterprise in the KBO register.
What is the turnover of MEDI-CL?
The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €53,591 and 34 comparable companies (NACE 862). It probably lies between €92,000 and €150,000.Financials
Is MEDI-CL profitable?
In financial year 2025, MEDI-CL made a profit of €34,564.
Where can I find the annual accounts of MEDI-CL?
MEDI-CL filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDI-CL due?
MEDI-CL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.